Reference
Ni L, et al. A single center research for outcome in patients receiving imatinib for steroid-refractory chronic GVHD after allogeneic stem cell transplantation. Bone Marrow Transplantation 52 (Suppl. 1): 221, Jan 2017 [abstract] - China
Rights and permissions
About this article
Cite this article
Imatinib. Reactions Weekly 1696, 194 (2018). https://doi.org/10.1007/s40278-018-44382-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44382-3